Bristol-Myers Squibb Company
Pharmaceutical manufacturer that stuffed wholesale distribution channels with $2B in excess inventory using financial incentives.
- Entity Name: Bristol-Myers Squibb Company
- Country of Domicile: US
- Listing & Ticker: NYSE (BMY).
- CIK / LEI Identifier: 0000014272.
- Industry Classification: Pharmaceutical Preparations (SIC 2834).
- Cumulative Overstatement: $2.0B across 1 enforcement episode(s).
- Assessed Penalties: $150.0M.
PRIMARY ENFORCEMENT CASES INVOLVING BRISTOL-MYERS SQUIBB COMPANY
1 CASE DOSSIERS| Case Title | Status | Primary Scheme | Overstatement | Total Penalties | Action Date |
|---|---|---|---|---|---|
| Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives | Settled, neither admitted nor denied | channel stuffing | $2.0B | $150.0M | September 20, 2006 |
FORENSIC PROFILE: BRISTOL-MYERS SQUIBB: $2B CHANNEL STUFFING WITH WHOLESALER INCENTIVES
FULL CASE DOSSIER →Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.
The company manipulated its accounting records by executing schemes under channel-stuffing. Financial reports filed with market regulators contained material misstatements that distorted true financial condition.
Fraud Window: January 1, 2004 to December 31, 2006 • Primary Regulator: U.S. Securities and Exchange Commission • Auditor: PricewaterhouseCoopers LLP
Documented Accounting Irregularities & Regulatory Findings
- CHANNEL STUFFING: Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand.
Primary Public Dockets & Actions
- [ENF-2004-bristol-myers-squibb] Enforcement Action: Bristol-Myers Squibb: $2B Channel Stuffing with Wholesaler Incentives (September 20, 2006): Offered wholesalers millions in inventory storage fees and price guarantees to ship excess pharmaceuticals ahead of demand. Official Record ↗